Three Motley Fool contributors have dividends on their minds as the second quarter of 2024 begins. And they think they've found some no-brainer dividend stocks to buy in April. Here's why they like AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Pfizer (NYSE: PFE). Keith Speights (AbbVie): What's ...
motleyfoolusx:gildusx:pfeusx:abbv
If you buy a dividend stock that's trading at a reduced price, it gives you the opportunity to take advantage of a higher-than-normal yield, and the chance to profit from a gain should the stock bounce back and recover in value. This is why loading up on dividend stocks after they have slumped, provided ...
motleyfoolusx:sbuxusx:gildusx:bce
